MEI Pharma Inc

MEIP13 Dec 2024
Healthcare
$2.78
0.00 (-0.37%)
Lowest Today
$2.65
Highest Today
$2.79
Today’s Open
$2.78
Prev. Close
$2.7
52 Week High
$6.69
52 Week Low
$2.61
To Invest in MEI Pharma Inc

MEI Pharma Inc

Healthcare
MEIP13 Dec 2024
0.00 (-0.37%)
1M
3M
6M
1Y
5Y
Low
$2.65
Day’s Range
High
$2.79
2.65
52 Week Low
$2.61
52-Week Range
52 Week High
$6.69
2.61
1 Day
-
1 Week
+5.26%
1 month return
-10.54%
3 month return
-6.97%
6 month return
-1.75%
1 Year return
-57.31%
3 Years return
-92.81%
5 Years return
-90.63%
10 Years return
-
Institutional Holdings
Anson Funds Management LP
16.41
Cable Car Capital LLC
9.18
Vanguard Group Inc
5.79
Vanguard Total Stock Mkt Idx Inv
3.02
Renaissance Technologies Corp
2.07
Vanguard Institutional Extnd Mkt Idx Tr
1.19
BlackRock Inc
1.12

Market Status

Fundamentals
Market Cap
18.66 mln
PB Ratio
0.75
PE Ratio
0
Enterprise Value
-19.69 mln
Total Assets
41.38 mln
Volume

Company Financials

Fund house & investment objective

Company Information
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
Organisation
MEI Pharma Inc
Employees
28
Industry
Biotechnology
CEO
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step